Back to search
FDAFDA · Food and drugs·Recall number D-0865-2016

8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only, Hospira Inc, Lake Forest, IL 60045, NDC 0409-6625-02

Published June 1, 2016 · Recall initiated: March 18, 2016

Summary

FDA records drug Class I recall D-0865-2016, published June 1, 2016 and initiated March 18, 2016. Recalling firm: Hospira Inc.; Status: Ongoing; Reported quantity: 72,000 units; Lot: Lot # 56-148-EV, Exp 8/1/2017. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: particulate matter identified as an insect in one vial.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot # 56-148-EV, Exp 8/1/2017
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only, Hospira Inc, Lake Forest, IL 60045, NDC 0409-6625-02 recalled?

Yes. FDA published recall D-0865-2016 on June 1, 2016. Reported hazard: Presence of Particulate Matter: particulate matter identified as an insect in one vial.

What should I do if I have this product?

Voluntary: Firm initiated · Letter